Bicycle Therapeutics (BCYC) Long-Term Deferred Tax (2022 - 2023)

Bicycle Therapeutics (BCYC) has 2 years of Long-Term Deferred Tax data on file, last reported at $88.6 million in Q4 2023.

• Quarterly Long-Term Deferred Tax rose 33.47% year-over-year to $88.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $88.6 million (up 33.47% YoY) and the FY2023 annual result came in at $88.6 million, up 33.47% from the prior year.
• Long-Term Deferred Tax grew to $88.6 million in Q4 2023, from $66.3 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $88.6 million in Q4 2023 to a low of $66.3 million in Q4 2022.